Value Stream Mapping for Pathology and Diagnostic Laboratories: From Specimen Receival to Verified Result Without the Batch Release Delay

In pathology and diagnostic laboratories, turnaround time is often discussed as though it were determined by analytical capability alone. The data frequently tells a different story. A modern analyser may complete its run in minutes while specimens spend many hours waiting in racks, queues, batch holds, validation worklists, or clarification loops.

Value Stream Mapping (VSM) makes this hidden time visible. It connects material flow (specimens, racks and result outputs) with information flow through the Laboratory Information System (LIS), courier portals, collection hubs and approval checkpoints.

This guide examines a representative stream handling 1,850 specimens per day across three collection hubs, from specimen receival through accessioning, pre-analytical handling, analytical processing, validation and verified result release.

1. Define the Value Stream Boundary

The selected start point is specimen receival: the moment the laboratory accepts physical custody of the specimen. The end point is verified result release to the clinician.

This boundary is strategically useful because it captures the laboratory-controlled portion of turnaround time. It includes:

• Courier arrival and specimen receival
• Barcode and identification checks
• Accessioning and pre-analytical triage
• Batch formation and analyser release
• Analytical processing
• Validation, repeat and delta-check review
• Verified result release through the LIS

It excludes collection-site activities before handover, while still allowing collection-hub defects to be fed back into the improvement system.

The laboratory’s average turnaround time is 41.6 hours, against a clinician expectation of 24 hours. Yet the analytical run itself occupies only 62 minutes. This contrast is the central improvement opportunity.

With 1,850 specimens received over 15.5 productive hours, demand creates a takt of approximately:

[
\text{Takt time}=\frac{15.5 \times 60}{1,850}=0.50\text{ minutes}
]

That is approximately 30 seconds per specimen, or 119 specimens per hour. The stream therefore needs controlled flow, rapid triage and carefully designed pull signals rather than large queues waiting for full batches.

For further guidance on defining an improvement boundary, see Scoping Lean Six Sigma Projects.

2. Current-State Map: Where the 41.6 Hours Go

The process map shows a familiar pattern:

1. Specimens arrive in uneven courier waves.
2. Receival and accessioning create a queue.
3. Specimens wait until an analyser batch reaches its minimum size.
4. The analyser completes its work in approximately 62 minutes.
5. Results accumulate in validation and delta-check queues.
6. Exceptions require repeat testing, clarification or formal approval.
7. Verified results are released to clinicians.

The analyser is not the primary bottleneck. Batch release, exception handling and validation flow are the constraints.

The stated 11.8 minutes of hands-on technologist time is a labour measure. The approximately 3% PCE uses the laboratory’s broader value-added elapsed-time definition, including controlled processing and verification activity. Keeping these measures separate prevents labour utilisation from being confused with end-to-end flow efficiency.

3. Quantifying All Eight DOWNTIME Wastes

The following waste profile combines direct baseline data with transparent planning estimates for items that require confirmation through time observation, LIS extraction or a physical spaghetti diagram. The estimates should be validated during the Measure phase.

Defects

At a 3.1% rejection rate, approximately 57 specimens per day are rejected at accessioning:

[
1,850 \times 3.1% \approx 57
]

The principal causes are haemolysis, insufficient volume and unlabelled specimens. At 19 minutes of re-collection effort per rejection, this represents approximately 18.1 hours of re-collection effort per day. Each rejection also extends the patient pathway by approximately 26 hours.

The 4.2% repeat or delta-check review rate represents approximately 78 results per day, while the 96.4% first-pass verification rate shows that approximately 3.6% require an additional verification path.

Overproduction

A planning audit estimate of 6% of daily orders being associated with panels or add-on tests not requested at the point of care would equal approximately 111 tests per day. At an estimated 1.8 minutes of review and handling per test, this creates approximately 3.3 hours of avoidable activity daily.

This figure should be confirmed by comparing ordered tests, authorised add-ons and clinician-requested panels.

Waiting

Waiting is the most visible contributor. Each analyser averages 47 minutes of waiting for a batch to reach minimum size, despite the analytical run requiring only 62 minutes.

A 47-minute queue represents approximately 94 specimens at the current takt rate:

[
47 \text{ minutes} \div 0.5 \text{ minutes per specimen}=94
]

The remaining elapsed time between the 62-minute analytical run and the 41.6-hour result turnaround is distributed across receival queues, validation, delta-checks, approvals and release holds.

Non-utilised talent

Scientists and technologists spend capacity on accessioning, telephone chasing and avoidable clarification rather than validation, method improvement and clinical support. A planning time study estimate of 2.5 FTE-hours per day assigned to these activities gives the improvement team a starting point for measurement.

The opportunity is not simply to reduce staffing effort. It is to redeploy specialist capability toward higher-value work.

Transportation

Specimens may move between collection hubs, courier consolidation points, central receival, accessioning, refrigerated holding and analyser benches. At only three additional transfers per specimen, the stream creates approximately:

[
1,850 \times 3=5,550\text{ specimen movements per day}
]

Each handoff introduces identity, custody and timing risk.

Inventory

Work in process includes specimens in receival racks, accessioning queues, refrigerated holding and validation worklists. At the current takt, one 47-minute batch queue equals approximately 94 specimen positions per analyser. Excess WIP also hides ageing specimens and makes the true priority sequence harder to see.

Motion

A physical spaghetti-diagram estimate of 2.4 kilometres of walking per shift (between accessioning, analysers, printers, racks and validation benches) would equal approximately 4.8 kilometres per day across two shifts.

Barcode-first triage, point-of-use labelling and a roving senior scientist can reduce this motion without compromising segregation or traceability.

Excess processing

Re-labelling, re-scanning and duplicate entry into the LIS and courier portal are classic over-processing activities. A planning estimate of 0.8 minutes per specimen would equal approximately 24.7 staff-hours per day across 1,850 specimens.

The correct countermeasure is not faster duplication. It is system integration, standardised data ownership and error-proofed entry.

4. Future-State Design: Build Flow Around Controlled Triggers

The future state should preserve analytical quality while replacing large queues with smaller, visible and governed flow.

Future-state design elements

1. Single-piece-flow accessioning
   Specimens are accessioned as they arrive rather than held for a large administrative batch.

2. Barcode-first triage
   The barcode becomes the primary identity and routing trigger. Exceptions are placed into a clearly defined error queue.

3. Courier arrival levelling
   Three hubs use six planned arrival slots to smooth demand and reduce uneven waves.

4. A 12-specimen analyser trigger
   The policy changes from waiting for a full batch to releasing when 12 specimens are ready, subject to assay, stability and quality requirements.

5. Auto-validation for stable assays
   Rules cover the stable 68% of assays, with defined limits for flags, critical values, QC status and delta checks. Exceptions remain under qualified review.

6. Roving senior scientist for delta checks
   One role owns the queue, resolves standard exceptions and escalates clinically significant variation.

7. Direct feedback to collection hubs
   Rejection Pareto data is returned to each hub, linking pre-analytical behaviour to patient delay and re-collection effort.

This design follows the DMAIC logic: define the service promise, measure actual flow, analyse root causes, improve the constraint and control the gains. A visual Andon-style signal can identify ageing queues or analyser exceptions in real time without requiring repeated phone calls.

5. Current Versus Future Performance

The annualised benefit should be framed in operational and clinical terms: faster clinician decisions, fewer avoidable recollections and approximately 4,100 re-collection hours released. Financial benefits may follow, but decision speed and patient experience remain the primary value measures.

6. 30/60/90-Day Kaizen Sequence

Days 1–30: Stabilise arrival and triage

Owners: Laboratory operations manager, courier coordinator, accessioning lead and hub supervisors.

• Implement six levelling slots across the three hubs.
• Pilot barcode-first triage on one specimen stream.
• Create a rejection Pareto by hub, defect type and shift.
• Establish an ageing visual board for receival and accessioning queues.
• Confirm baseline distributions using averages, medians, box plots and time stamps.

Days 31–60: Improve run release and validation

Owners: Technical operations manager, analyser lead, LIS analyst and quality manager.

• Test the 12-specimen analyser trigger.
• Validate analytical stability, QC and safety conditions.
• Build and approve auto-validation rules for the stable 68% of assays.
• Measure queue age, throughput, repeat rate and first-pass verification daily.
• Use formal approval checkpoints for governance, while limiting unnecessary approval routing that creates bottlenecks.

Days 61–90: Sustain the new operating system

Owners: Senior scientist, quality manager, hub supervisors and Black Belt project lead.

• Introduce standard work for delta-check ownership.
• Launch the hub feedback loop for rejected specimens.
• Place control charts on rejection rate, turnaround time and first-pass verification.
• Review special-cause variation within 24 hours.
• Conduct a weekly governance review covering safety, service, capacity and improvement actions.

Build the Capability to Lead the Change

A pathology VSM is not merely a diagram. It is a management system for connecting customer value, process capability, variation, throughput and clinical risk. White Belts can build awareness, Yellow Belts can support local improvements, and Green or Black Belts can lead the cross-functional DMAIC programme across hubs, LIS teams, scientists, couriers and clinical stakeholders.

For structured development, explore CSSC-accredited Lean Six Sigma online training, Yellow Belt training or Black Belt training.

Enrol in CSSC-accredited Lean Six Sigma training and build the capability to map, improve and control diagnostic laboratory performance.

Kaizen. Kai-Care. Kai-Done. Lean Six Sigma.